Comparing DSM-IV and ICSD-2 Classifications for Reliable Insomnia Diagnosis

by

It is a sleep disorder that affects millions of people across the globe and results in individuals experiencing chronic sleeplessness, fatigue, and overall negative effects on health. There are several diagnostic models that have been developed in the years with the aim to classify insomnia and facilitate appropriate treatment. There are two well-known classification systems that include the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) and the International Classification of Sleep Disorders, 2nd version (ICSD-2). These two systems intend to provide the framework for diagnosing insomnia but do that in somewhat different ways as to the criteria, definition, and the way they address the subtypes of insomnia. Thus, comparing the organization of the DSM-IV and the ICSD-2, it is possible to understand how each system deals with the comorbidity and possible causes of insomnia. This article offers a comprehensive look into the advantages and disadvantages of each system, with emphasis placed on their performance and value in real-life practices.

The DSM-IV Approach to Insomnia

The DSM-IV is mostly applied by psychiatrists and other mental and physical health specialists and gives several options for diagnosing insomnia depending on its link to the other conditions. According to DSM-IV criteria, insomnia is a disorder that is manifested by problems in the onset or maintenance of sleep or poor quality sleep that causes clinically significant distress or interference with work or other daily activities.

The advantage of this classification used in DSM-IV is the mutual division of insomnia into primary and secondary types. The DSM-IV describes primary insomnia as not resulting from any concurrent medical or psychological disorder. Secondary insomnia is associated with another primary mental disorder, a medical condition, or substance use. In this respect, this distinction has been central to the DSM-IV’s classification of insomnia as a condition often attributable to other conditions that may cause the sleep disorder in a patient.

The DSM-IV also outlines subtypes of insomnia that are associated with other conditions. For instance, the category “Insomnia related to another mental disorder” is one of the most frequently applied diagnostic labels for insomnia, especially when referring to its development in psychiatric facilities. Some cases are sleep difficulties; patients with depression, anxiety, or other mood disorders fall under this category. Second, “primary Insomnia due to a medical record” pertains to conditions where other health issues, including pain or neurological disorders, affect sleep.

In contrast to the DSM-IV system, which, although valuable for identifying the coexisting conditions that may affect sleep, has been criticized for its dichotomy of primary and secondary insomnia, which does not satisfactorily account for the nature of insomnia. Often, insomnia involves more than one factor, and, as a consequence, it becomes challenging to categorize sleep disturbances systematically. In addition, the DSM-IV procedure for assessing sleep disturbances in individuals is based on the patient’s’ own reports on the quality of their sleep and thus yields inconsistencies contributing to the low inter-rater reliability of the classification.

Yearwise Publication Trend on “insomnia”

Find publication trends on relevant topics

The ICSD-2’s Comprehensive Framework

The second version of the International Classification of Sleep Disorders (ICSD-2) released, proposed by the American Academy of Sleep Medicine, provides a more detailed and sleep-oriented approach to the diagnostic resolution of insomnia. The ICSD-2 identifies 37 distinct types of insomnia, categorized into six major groups: These can be: insomnia, sleep-related breathing disorders, hypersomnias of central origin, circadian rhythm sleep disorders, parasomnias, and sleep-related movement disorders.

The ICSD-2 system is especially beneficial in that it focuses on physiological and behavioral features of sleep. Compared to the DSM-IV, which categorizes insomnia mainly in relation to other health or mental health disorders, the ICSD-2 offers a more detailed classification of insomnia according to different forms of sleep disruption. It is advantageous in diagnosing the sleep disorder in a more accurate way since the condition may not be as a result of another disease.

For example, the ICSD-2 subtypes that are in the DSM-IV include “psychophysiological “insomnia,” and this is where a patient’s anxiety or concern regarding sleep becomes the primary reason why a patient may not get a proper sleep. The system also incorporates “paradoxical Insomnia,” a condition in which the patients claim to suffer from insomnia but show little signs of sleep disorders during polysomnography. This category solves one of the problems that were present in DSM-IV methodology, namely differences between the complaints a patient has about sleep and the results of objective analyses of this process.

It is also important to consider another strong side of the ICSD-2: “idiopathic insomnia,” which is defined as a lifelong disease starting in childhood that is not related to other medicine or psychological diseases. This category recognizes the fact that there may be cases of insomnia where no definitive causes are ascertained, thus providing a concept that explains chronic insomnia other than the DSM-IV primary insomnia categorization.

Furthermore, the ICSD-2 also encompasses other sleep disorders that coexist with or are related to insomnia, like sleep-related breathing disorders, including sleep apnea, and sleep-wake disorders, including delayed sleep phase syndrome. This is a major advantage of the approach described here, as it offers a wider perspective of a patient’s sleeping problems, enabling the clinician to find and address several ailments that could be underlying the sleep issues.

Comparing the Two Systems

They also differ on how they deal with the cause of insomnia, in that the DSM-IV seeks a causal explanation of the condition as compared to the ICSD-2. While the DSM IV emphasizes separating primary insomnia from insomnia caused by other factors, the approach can be helpful. Clinicians should attempt management based on the root cause of the condition. However, with this approach, one may fail to capture a rather intricate process, which leads to insomnia. For instance, a patient with chronic pain and depression may show complaints of insomnia possibly arising from the pain and the depression. The classification of the DSM-IV could lead to the diagnosis of secondary insomnia for either condition while failing to capture the complexity of the patient’s sleep disorder.

However, the classification system of the ICSD-2 is much more comprehensive and fluid than the DSM-IV, with the ability to diagnose insomnia as having many causes. Also, the ICSD-2 classifies insomnia into specific subtypes like psychophysiological and paradoxical insomnia, thus helping to present a clearer picture of sleep disorders. This ensures that clinicians formulate different management plans that attend not only to insomnia but also to the behavioral or physiological cause.

The second major difference between the two systems is that specific objective sleep measurements are obtained in the ICSD-2. Compared to the DSM IV, the ICSD-2 focuses more on the patient’s self-reported symptoms, although it encourages the use of instruments such as polysomnography to collect quantitative information about the sleep of the patient. This approach may enhance the objectivity of insomnia diagnoses since it shall be complemented with concrete evidence of sleep disruptions, contrary to cases where reliance is made on self-reports only.

Nevertheless, there are some weaknesses that have to be pointed out regarding the use of the ICSD-2 system. A weakness associated with the ICSD-2 is the test complexity. For a clinician who is not well versed in sleep medicine, the classification system is extensive, with 37 categories of insomnia. The ICSD-2 may take longer to use in clinical practice since the disorders described are more detailed compared to the ICSD-1, and sleep studies might not always be easily accessible. However, it is a system that seems to present less complexity than the ICD-10-GA and would seem to be more feasible in general medical or psychiatric settings, even if it provides less detail.

Recent Publications on “insomnia”

Find publications on relevant topics

Reliability and Validity of Diagnose Settings

Insomnia diagnosis: Comparing the reliability of the DSM-IV with the ICSD-2 Thus, the DSM-IV and ICSD-2 have their advantages and disadvantages for diagnosing insomnia. The categories defined in the DSM-IV are quite broad but are, for the most part, supported by clinical research and have been widely in use in the field of psychiatry. Its concentration on mental health-related insomnia is rather useful in clinical settings due to the high correlation between sleep disorders and such mental health ailments as depression or anxiety.

However, the DSM-IV criteria prove somewhat restricted, especially when the origin of insomnia is ambiguous or complex. For example, organizing insomnia into primary and secondary in the DSM-IV excludes the possibility of comorbid sleep disorders that may stem from more than one cause. This can result in failure to diagnose the restricted nature of the problem or to provide comprehensive treatment that manages all the facets of sleep disturbances.

The ICSD-2, however, presents a more comprehensive and nuanced picture of insomnia than does the DSM-IV. Greater specificity of diagnoses, owing to identification of several subtypes of insomnia, also results in more focused treatment options. The use of both quantitative and qualitative data in the system also improves the diagnosis reliability since it integrates data from the sleep studies and other diagnostic instruments.

However, there are certain drawbacks associated with the structure and design of the ICSD-2 that might make its applicability in some clinical contexts somewhat circumscribed. Some of these issues are as follows: The assessment procedure required by ICSD-2 may require specialized testing. Instrumentation may thus not be feasible or easy to conduct in all clinical settings due to the complexity of the ICSD-2. Therefore, due to the complexity of implementing ICSD-2 in general practice or a psychiatric clinic that may not have access to sleep labs, clinicians fall back on the simpler DSM-IV system of diagnosing insomnia.

Conclusion

However, both the DSM-IV and the ICSD-2 provide useful diagnostic models for insomnia that have pros and cons. The DSM-IV is more useful, especially in the context of mental health, because the emphasis is on the connection between insomnia as a symptom and the presence of psychiatric disorders. However, it relies on categories that are too general, and the reports from the respondents are often biased.

The ICSD-2 has more effective classifications about the subtypes of insomnia and more focuses on objective parameters for sleep disorders. It is disadvantageous in general practice due to its complexity, but the ICSD-2 provides a more detailed diagnosis and approaches the management of insomnia in a way that targets the cause.

In the end, the decision of which particular classification to use—the DSM-IV or the ICSD-2—will solely depend on the clinical circumstances, availability of diagnostic instruments, and the patient’s needs and challenges. Through integration of the two systems, clinicians are in a better position to diagnose and treat insomnia in a more efficient and accurate manner.

References

  1. Edinger, J.D., Wyatt, J.K., Stepanski, E.J., Olsen, M.K., Stechuchak, K.M., Carney, C.E., Chiang, A., Crisostomo, M.I., Lineberger, M.D., Means, M.K. and Radtke, R.A., 2011. Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses: results of a multitrait-multimethod analysis. Archives of general psychiatry, 68(10), pp.992-1002.
  2. Buysse, D.J., Reynolds 3rd, C.F., Hauri, P.J., Roth, T., Stepanski, E.J., Thorpy, M.J., Bixler, E.O., Kales, A., Manfredi, R.L. and Vgontzas, A.N., 1994. Diagnostic concordance for DSM-IV sleep disorders: a report from the APA/NIMH DSM-IV field trial. The American journal of psychiatry, 151(9), pp.1351-1360.
  3. Littner, M.R., Kushida, C., Wise, M., G. Davila, D., Morgenthaler, T., Lee-Chiong, T., Hirshkowitz, M., Loube, D.L., Bailey, D., Berry, R.B. and Kapen, S., 2005. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep, 28(1), pp.113-121.
  4. Dinges, D.F., Pack, F., Williams, K., Gillen, K.A., Powell, J.W., Ott, G.E., Aptowicz, C. and Pack, A.I., 1997. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4–5 hours per night. Sleep, 20(4), pp.267-277.
  5. Walters, A.S., Aldrich, M.S., Allen, R., Ancoli‐Israel, S., Buchholz, D., Chokroverty, S., Coccagna, G., Earley, C., Ehrenberg, B., Feest, T.G. and Hening, W., 1995. Toward a better definition of the restless legs syndrome. Movement disorders: official journal of the Movement Disorder Society, 10(5), pp.634-642.
  6. Vernet, C. and Arnulf, I., 2009. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep, 32(6), pp.753-759.
  7. Andlauer, O., Moore IV, H., Hong, S.C., Dauvilliers, Y., Kanbayashi, T., Nishino, S., Han, F., Silber, M.H., Rico, T., Einen, M. and Kornum, B.R., 2012. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep, 35(9), pp.1247-1255.
  8. Bradshaw, D.A., Yanagi, M.A., Pak, E.S., Peery, T.S. and Ruff, G.A., 2007. Nightly sleep duration in the 2-week period preceding multiple sleep latency testing. Journal of Clinical Sleep Medicine, 3(6), pp.613-619.

Top Experts on “insomnia“